Redpoint Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$432K Sell
3,524
-1,603
-31% -$211K 0.06% 355
2022
Q2
$682K Sell
5,127
-131
-2% -$17.9K 0.08% 301
2022
Q1
$720K Hold
5,258
0.07% 327
2021
Q4
$910K Sell
5,258
-669
-11% -$102K 0.07% 314
2021
Q3
$861K Buy
5,927
+2,626
+80% +$384K 0.07% 307
2021
Q2
$436K Hold
3,301
0.04% 494
2021
Q1
$424K Hold
3,301
0.04% 483
2020
Q4
$393K Hold
3,301
0.04% 422
2020
Q3
$378K Sell
3,301
-9,516
-74% -$1.12M 0.04% 423
2020
Q2
$1.46M Sell
12,817
-380
-3% -$40.3K 0.08% 281
2020
Q1
$1.06M Hold
13,197
0.07% 317
2019
Q4
$1.41M Sell
13,197
-933
-7% -$97.3K 0.07% 327
2019
Q3
$1.51M Sell
14,130
-501
-3% -$51.4K 0.08% 305
2019
Q2
$1.49M Sell
14,631
-1,351
-8% -$130K 0.08% 303
2019
Q1
$1.44M Hold
15,982
0.07% 320
2018
Q4
$1.33M Sell
15,982
-1,058
-6% -$99.2K 0.08% 302
2018
Q3
$1.84M Sell
17,040
-3,346
-16% -$367K 0.09% 259
2018
Q2
$2.24M Sell
20,386
-18,059
-47% -$1.88M 0.12% 221
2018
Q1
$3.86M Hold
38,445
0.21% 129
2017
Q4
$3.79M Buy
+38,445
New +$3.64M 0.21% 132

Other funds holding DGX

Redpoint Investment Management's DGX Position: Q3 2022 in Review

Redpoint Investment Management reduced its Quest Diagnostics (DGX) stake by 31% in Q3 2022, selling an estimated $211K and leaving 3,524 shares worth $432K. The position accounts for 0.06% of the portfolio, ranked #355.

Redpoint Investment Management first reported a position in DGX in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.86M in Q1 2018. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Redpoint Investment Management held 3,524 shares of Quest Diagnostics worth $432K as of Q3 2022.
  • Redpoint Investment Management sold 1,603 Quest Diagnostics shares in Q3 2022, an estimated $211K.
  • Quest Diagnostics made up 0.06% of Redpoint Investment Management's portfolio in Q3 2022, its #355 holding.
  • Redpoint Investment Management first reported a position in Quest Diagnostics in Q4 2017 and has held it in 20 quarters since.
  • Redpoint Investment Management's Quest Diagnostics position peaked at $3.86M in Q1 2018.
  • 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.